has been shown to provide superior pain relief when compared with standard therapy options for postoperative analgesia. IfPCA is to be implemented widely in teaching, private and country hospitals, its effectiveness needs balanced with a high safety profile. This can be achieved by consideration of patient selection, comprehensive education of patients, medical and nursing staff and equipment familiarisation. Continuous clinical audit allows identification of problem areas along with monitoring analgesic efficacy.
first thousand patients involved with PCA in a district general hospital in the U.K. showed that technical problems (e.g. deprogramming and disorders of trigger mechanism) were more common than adverse clinical effects. 5 Respiratory problems occurred in 2.5% of all patients on PCA, but in less than half of these patients was it necessary to stop the PCA treatment prematurely. Two factors may be responsible for the apparently low complication rate. First, PCA machines are not available in the majority of hospitals: insufficient numbers of machines to cover all postoperative patients dictate that these are used on a preselected group who may be in general fitter, younger and undergoing more major surgery. Second, it is still the case that PCA is being popularised by a relatively small group of enthusiastic anaesthetists who spend considerable time pre-and postoperatively in the management of these patients.
There are groups of patients in whom PCA may be unsuitable, or potentially dangerous and difficult to administer. Careful preoperative assessment will help to exclude these cases. Awareness of the aims and limitations of the treatment, for both nursing and medical staff, becomes better developed following comprehensive education. Similarly, patients undertaking PCA therapy need teaching in the technique along with information regarding potential worries they may have about the therapy. Dramatic technological advances with PCA equipment over the past five years have dictated the equipment familiarisation is essential for all involved in its delivery. IfPCA is to be used safely in any hospital, its introduction must have minimal impact on current nursing and medical routine. Moreover, potential problems and interactions between the different components of the PCA system are becoming evident. Finally, clinical audit is ess~ntial to allow critical appraisal ofthe efficacy of this treatment modality along with potential adverse effects. PATIENT 
SELECTION
For the technique to be effective, patients must be able to understand the mechanism of their analgesia. A painful stimulus must be assessed by the patient who can subsequently elicit an appropriate response, i.e. a push of the PCA button. This may not be possible in the very young, who are unable to make the connection between pain and relief; the very old, whose short term memory may preclude the retention of even the simplest of instructions; and in those patients with acute confusional states or organic brain syndromes.
Although most patients cope well with PCA there are some in whom the concept of complet~ control may be intimidating and where PCA is totally unsuitable. 6 The success, therefore, of this therapy can be significantly limited by the psychological make-up of the patient. The concept of ' locus of control' was described in the mid-sixties by Rotter 7 and subsequently developed into a Multidimensional Health Locus of Control (MHL9 sca~e that categorised patients depending on then attitudes to behaviour and subsequent reinforcement. 8 Those who see their own actions as contributing to the reinforcement have an 'internal' locus of control and tend to be active in controlling their environment. These patients respond well to PC~ and are able to use it effectively. Conversely, patients who have an 'external' locus of control relate positive reinforcement to other people or events, resulting in loss of control, strong reliance on others and failure of the technique. Neuroticism, anxiety state and anxiety trait are positively correlated with postoperative pain scores. 9 Whether preoperative questionnaires are a practical screening procedure for institution of PCA is under debate. 9 ,lo Until a uniform reproducible and simple assessment is available' clinical impression and evaluation by the physicia~ and nurse will be the most important aspect in patient selection. Patients who are intravenous drug abusers present a particularly difficult problem both in assessment of analgesic requirements and therapeutic effect. The analgesic end-point sought by .non-addicted patients is tempered by their desne to stay as alert as possible. Keeri-Szanto contrasted these to addicted patients who ' ... administered narcotics to the brink of unconsciousness, "coming up for air" only long enough to trigger the administration of more drug:''' So~e cen~res allow intravenous (e.g. herom), and mhalatlOnal (e.g. cocaine and 'crack') dru~ abusers, free access to their PCA service.'2 Patients suspected of seeking 'high' rather than analgesia, or tampering with the PCA devices have these withdr~wn. Reliance is placed on the h~nesty of these patients to comply with treatment. We have found.PCA l~ss than ideal with these patients, ?ue to then c~:mtmuous drug-seeking behaviour, mterfere~~e with ~CA devices and manipulative personalities. Reliable feedback concerning the efficacy of the treatment cannot be differentiated fro~ a desire to obtain a 'high'. The increased nursmg and medical time that is involved with using PCA in these patients must be considered especially when it may interfere with the treatment of ?ther patients and result in damage to equipment.
The consideration of patients for PCA who are or who may become hypovolaemic presents another ?ifficult ther~~eutic dilemma. Analgesic agents are Ideally admmlstered to these patients in small intravenous boluses, yet constant assessment of neurological and cardiovascular parameters is essential, due to the preferential distribution of blood flow to the heart and brain in such shocked individuals ( Figure I) . Whilst the problems of erratic absorption and potential bolus administration following reperfusion are r~c?gnised with intramuscular injection, opinion is diVided as to whether PCA is safe in this group of patients. In a recent study of ours in which different sized bolus doses for PCA were compared, two patients developed respiratory depression requiring naloxone administration. Both of these patients had hypovolaemia secondary to covert blood loss. 13 This supports recommendations made by Tamsen and colleagues l4 that patients who have labile cardiovascular parameters are unsuitable for PCA and contrasts with the experience of Notcutt who advocates the usefulness of PCA in this group of patients. s Caution is advised if PCA is used in any patient with an unstable cardiovascular system. Careful pre-and postoperative assessment by anaesthetic and nursing staff will help to identify all these patient subgroups and assess their suitability for PCA accordingly.
EDUCATION
Comprehensive education of patients, relatives, nursing and medical staff, both anaesthetic and surgical, can be the most important measure to ensure safety and efficacy of PCA. Patients can be educated by the anaesthetist at the preanaesthetic clinic and/or preoperative visit, and this should be reinforced by ward and theatre staff. Patients' expectations and apprehensions need to be identified preoperatively before PCA is instituted. A recent survey revealed that the main disadvantage of PCA as perceived by patients preoperatively was a reduction in the total time spent in contact with the nursing staff. IS A smaller number worried about equipment failure, overdosage and addiction potential, whilst interestingly, very few saw PCA as a way of totally relieving pain. The control of the pain seemed as important as the amount of pain reduction experienced.
Other workers have indicated that careful and time consuming preoperative education for patients intending to use PCA does not influence their ability to adequately self-administer analgesia. 9 Although this can be reassuring for those patients who have missed preoperative education it does not indicate that it is of little value. There are often worries and apprehensions that will only become apparent when instructing patients on the use of PCA. The goals and safety features of PCA also need explanaton to relatives. In some circumstances, e.g. parent-controlled analgesia, relatives are given formal training and are encouraged to assist their children in activating the PCA device. 16 However, this breaks the negative feedback loop, whereby excessive sedation prevents the administration of further amounts of opioid. It can also be broken by concerned partners who activate the pumps for the patient. Obviously the consequences can be disastrous. 17 Manufacturers of PCA devices are now producing patient information sheets that attempt to explain and to answer in an attractive and simple way the use of PC A and worries that patients may have, and these also emphasise positive features of this treatment option. The value of these has not been studied. Work in other areas has shown that simply handing the patient such information is not enough, and that reinforcement by nursing and medical staff is essential for information to be adequately and efficienly relayed.
Education of nursing staff is ideally carried out by a dedicated nurse educator, whose aims are to teach the basic principles of PC A, potential adverse effects, evaluation of problems and intervention strategies. This needs to be addressed in all areas where PCA is being used and theatre, recovery and especially ward staff need to be fully aquainted with the theoretical and practical components of the technique, the equipment and the monitoring. Staffing changes along with quality assurance programs dictate that this cannot be accomplished in one visit so that ongoing education is essential to ensure continuity of care and prevention of mishaps.
Medical staff, both anaesthetic and surgical, need to be fully aware of treatment options, equipment and its limitations, aong with potential problems before prescribing PCA. Historically the prescription and assessment of postoperative analgesia was under the control of the surgical team. The role of the anaesthetist in the postoperative period has grown in recent years in some hospitals to include fluid balance, parenteral nutrition and now more than ever the prescription and delivery of analgesia. IS Surgeons may view this as interference if adequate information and communication is not presented by the anaesthetic staff. The inception of acute pain services has helped in providing a co-ordinated team approach, so that problems relating to PCA can be collected centrally and a rapid and effective resolution facilitated. 19 Anaesthetists who prescribe PCA need to be aware of the variants and variables involved in its administration. 2o Variants include bolus demand, infusion demand, bolus demand plus constant infusion, and bolus demand with variable infusion. The variables involved are the drug itself, dose size, maximum dose and lockout interval. Although most variants are available with all PCA machines, the variable infusion rate was only present on one device. 21 When considering variants and variables of PCA, results of studies should not be extrapolated beyond the context of their design. Several studies have concluded that the addition of a background infusion of morphine to PCA fails to improve analgesic effect, despite the administration of a larger dose of opioid 2 and may increase side-effects such as sedation and confusion,23.25 while other workers support the benefits of a background infusion to increase analgesic efficacy. 26 In another study, patients tended to seek analgesia, reflected as number of boluses, at the same rate, irrespective of the bolus dose size, suggesting that the actual bolus size prescribed is not as critical as previously thought. 13 These studies only reflect experience with morphine, and further work with other opioids is needed. Safe prescribing of PCA depends on a thorough knowledge of the current PCA literature along with sound clinical experience. EQUIPMENT Malfunction of equipment was one of the biggest worries of the pioneers of peA, yet the paucity of articles regarding mishaps would suggest that such problems are not common. Equipment used for the administration of peA can be considered to fall into two major components, the pump itself, and the accessories (e.g. the drug reservoir, delivery tubing, anti-reflux valves and patient push-buttons).
Several peA pumps are currently approved for use in Australia ( Table 1) . Ideal characteristics of peA pumps were suggested by Norman at the first International Workshop on Patient-controlled AnalgesiaY Experience with a variety of pumps over the past six years has led us to propose the optimal characteristics of a peA pump. These should be borne in mind when considering purchase of these pumps.
Dual power supply:
If mains operated, a reliable and long-acting battery back-up is required, with memory of previous program retained. Battery-only devices have the major advantage of portability and minimal hindrance to patients who may be ambulant. However, the battery life must be sufficiently long duration to allow uninterrupted use for individual patients, along with accurate rates of delivery at variable voltage inputs.
Drug specific pumps:
These are designed for individual agents, which negate the need to calculate concentrations and rates for individual drugs. Manufacturers' modifications of existing pumps, such as with plastic overlays that clearly identify the drug in the syringe along with the route of administration and communicate this information to the pumps' microprocessors, can be made. 28 This may also help prevent the potential problem of attaching an intravenous line to an epidural or administering a drug destined for a vein into the epidural space. This has occurred with cephazolin,28 thiopentone,29 diazepam,3o potassium chloride 31 and total parenteral nutrition 32 with variable neurological sequelae.
Programming:
The program should be simple to run, with no more than two steps needed to initiate any particular variable change. Menus should be easily read, illuminated for night-time use, along with clearly labelled prompts on the screen. Once programmed, the machine should scroll the completed peA prescription for review before starting the infusion. Limits need to be set for maximum drug concentration, infusion rate, bolus rate and lockout interval. Alternatively, these can be inbuilt, and will be specific for each particular drug. Software protection against current surges and static interference is essential, not only to provide protection for the pump but also to prevent reprogramming and inactivation of alarms. The Graseby PCAS recently underwent a voluntary recall following the unprogrammed infusion of drug into a patient resulting from an electrostatic disturbance (ESD) associated with reconnection of a power cord. 33 Software modifications along with protection against ESD may help prevent such problems in the future. One PCA pump under development (by Bard) will have interchangeable preprogrammed 'chips' inserted into the pumps, so not only can the pump be dedicated to a particular drug, but a customised prescription for different modes of delivery and patient requirements can be used, thus removing yet another potential source of error, the setting-up of the PCA prescription.
Activation buttons:
The patient-machine interface needs consideration so that a continued pressure does not lead to persistent drug delivery and overdose. 34 Ideally, activation of the pump should be initiated by a double button push 35 or release of a cover on the activation button 36 to prevent the accidental initiation of a bolus. By acting as a reaction-time tester, it may reduce the chance of a confused or sedated patient inappropriately demanding another dose. Fears that patients may not be able to carry out this more complicated activation process have not been confirmed in clinical practice.
Alarms:
These should be of two types, relating to the significance of the problem and should combine audible and visible components; e.g. a quiet, lowpitched alarm to warn against low battery, and a louder high-pitched alarm to warn against air in line, line occlusion or empty syringe is advantageous. The patient should not be able to interfere with or silence these alarms.
Physical characteristics:
Pumps need to be lightweight, robust and able to tolerate minor trauma, while their action should be silent to minimise disturbance to patients and those around them. Accuracy of the pump should be within 10% of set values. 37 The high internal resistance of PC A pumps combined with the use of high-volume syringes necessitates these devices generating high driving pressures. 38 It is important that in combination with epidural catheters and filters, the delivery characteristics are not altered and that occlusion alarms are not continually activated by the high line pressures that are generated. 39 
Security:
To avoid 'tampering' by untrained staff or patients it is mandatory that the analgesic reservoir cannot be detached from the pump during use. As most solutions are dilute, and due to the increasing use of epidural opioids, drug volumes required for PCA devices are often large. This requires the frequent changing of syringes. As most medication mishaps are due to errors in making up solutions and initiating treatment, a large reservoir would be beneficial in reducing changeovers. This is present in the Abbott Pancretec Provider 5500 PCA, Bard Ambulatory pump and Pharmacia 5800 PCA device, which can house reservoirs containing hundreds of millilitres in a portable sealed case.
Some pumps (e.g. models in the Abbott Lifecare series and a version of the MDS 110 PCA) have used dedicated prefilled syringes that can be replaced as necessary. Thomas and Owen reported a case of respiratory depression caused by a crack in a glass syringe leading to siphoning of a significant dose of morphine into a patient. 4o Two factors combined to produce this complication; the presence of the crack allowed air to gain entry into the system whilst the adhesive label held the broken cartridge together, thus simultaneously preventing the loss of drug. The siphoning effect was compounded, the pump being placed at a higher level than the patient.
Intravenous PCA is commonly administered into the same cannula as the maintenance fluid. The importance of using anti-reflux valves in this situation has been reviewed in detail elsewhere. 41 They are of value in preventing the retrograde flow of analgesic in the parallel line following an occlusion. Once the obstruction is released, a potentially dangerous bolus may be suddenly presented to the patient. The characteristics of the ideal anti-reflux valve are shown in Table 2 . Largebore tubing is needed to prevent retardation of fluid flow if resuscitation is required. Valves and tubing of low complicance prevent the occurrence of a large stored volume of analgesic that may occur if a pump continues to work against an obstruction. This may be subsequently delivered as a bolus to the patient. Thus careful matching of pumps to delivery systems and drug dilutions is of great importance. The potential bolus delivery from one pump and delivery system following release of an occlusion could be up to the equivalent of 6 mg of morphine, whilst from another pump using the same system the bolus may only approximate to 2
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• Unstimulated Respiratory Rate and Pattern
CO-ORDINATOR IF:
(count full minute) 1. respiration <a/minute and shallow • Sedation Score: mg. 4t The compliance ofthe system affects not only the stored volume characteristics but also detection of occlusion alarms. For instance the Provider 5500 system has very low compliance so that occlusions are detected rapidly, but this can be defeated ifit is then attached to a compliant extension tube which will result in a longer time to detect an occlusion, a large stored volume and therapeutic failure. As with any valve it is important that the direction of permitted flow cannot be altered by the patient or untrained staff. One version of the Cardiff valve which changed the direction of flow by rotation of an external tap had this potential problem. Fluid administration sets with an integral anti-reflux valve, used in conjunction with dilute analgesic from the peA device, may prove to be the safest and best; e.g. TUT A giving set (Lane Cove, N.S.W_)_ Finally the characteristics of the administration set with respect to the potential for siphoning have important consequences if not appreciated. The Provider 5500 PCA pump, which has a dedicated cartridge for administration, can allow fluid to flow freely intravenously when disconnected from the pump. This only occurs with the intravenous mode of PCA and is compounded when the pump is placed higher than the patient. 39 This potential problem was highlighted by a recent ECRI report (vide infra) which advocated the use of gate clips when changing cartridges or syringes. 42 
MONITORING

Equipment
Careful monitoring will prevent the advent of most mishaps with PCA. The patient needs monitoring for side-effects and efficacy of treatment, as do the pump and delivery system_ This can be carried out at several levels in order to optimise safety.
Biomedical engineers, along with anaesthetic technicians, have an important role in preinstallation tests and quality control. All pumps should be bench-tested and should fulfil their technical specifications. Guidelines set out by Anaesthesia independent non-government departments, e.g. ECRI (Emergency Care and Research Institute, Philadelphia, U.S.A.), need to be followed. Once the pumps are in service, continued surveillance of function is essential so that recurrent or potential faults can be identified and rectified. Log books dedicated to each pump help in identifying periodic faults in particular pieces of equipment, so that these items are removed from service and the fault rectified rapidly.
Pharmacy staff are able to provide another tier of safety and in some institutions provide the mainstay of initiation and maintenance of PCA. They can prepare analgesic solutions in a more controlled environment than on the ward, develop prescription forms, provide informational backup relating to drug compatabilities and generally supervise the pharmaceutical component of the therapy.
PATIENTS
The goals in monitoring patients are twofold; to minimise adverse effects whilst optimising the analgesic efficacy.
Adverse effects of this therapy include nausea, vomiting, pruritus and urinary retention. The most significant, however, are excessive sedation and respiratory depression. 19 In our hospital, all patients who are on PCA have their respiratory rates, amounts of sedation, pain scores, numbers of good tries, total numbers of tries and volumes remaining in the syringe measured hourly. If any of the parameters falls outside previously determined values, a preset algorithm is initiated by nursing staff (Figure 2 ), whilst medical advice is being sought. The dangers of intravenous PCA and epidural or spinal opioids are frequently debated, yet do these methods predispose patients to an increased risk of respiratory depression or excessive sedation? The experience of one acute pain service following its first year of service would indicate that in practical terms there are few problems. 43 The incidence of significant respiratory depression was zero in the epidural group (177 patients) and 0.5% in the intravenous PCA group (747 patients). Hypotension had an incidence of 1.7% with epidural analgesia whilst there was no instance with the intravenous PCA group. Nausea and vomiting remained the single most significant complication. Overall, 37.3% of the epidural patients and 34.8% of intravenous PCA patients experienced nausea or vomiting. It must be noted however, that these figures were obtained by intermittent clinical assessment rather than intensive and comprehensive electronic surveillance. Brose et at. used continuous pulse oximetry to compare the respiratory effects of three treatment modalities for postoperative analgesia following caesarean section; epidural morphine, PCA and intramuscular opioids. Mild de saturation (90-95%) occurred most frequently with PCA (25% of total time), whereas less frequent but more severe desaturation occurred in the epidural group. 44 In another study where epidural diamorphine, intravenous PCA diamorphine or parenteral morphine were administered to patients before and 24 hours following surgery, respiratory depression again evaluated by continuous pulse oximetry was most pronounced with the epidural group,45 however, the other groups also experienced periods of desaturation. Studies using pulse oximetry have begun to highlight the prevalence of respiratory problems in the perioperative period, both in quantity and quality. These respiratory disturbances are known to occur for up to two weeks following elective surgery46 and the detrimental effect of altered sleep patterns, along with opioid-related respiratory effects have been recently suggested as important factors involved in perioperative desaturationY The limitations of using respiratory rate as an assessment of opioid overdo sage are well documented 48 and on pure clinical grounds the characteristics of the pattern of breathing and conscious level are probably of greater significance than the frequency of ventilation. A variety of devices have been used for postoperative respiratory monitoring and include inductive and impedance plethysmography, ultrasound, capnography, pneumotacography, transcutaneous monitoring, thermistor and movement monitors. All have drawbacks and most are at present research tools. Pulse oximetry is now considered essential for intraoperative monitoring. Future trends may dictate that its use in the postoperative period become standard for the majority of patients. The development and introduction of radio-telemetry applied to oximetry will enable several patients to be monitored simultaneously from a central console, thus making it more practical in the general ward setting. The 'Infuscommand' is a PCA device incorporating pulse oximeter control feedback, which prevents patients receiving demands if their oxygen saturation is below a preset leve1. 49 Other advances in electronics may produce smaller PCA machines with feedback from the patient (e.g. airflow movement at the nose or verbal patient commands) which can prevent excessive drug delivery.
A PCA service needs to evaluate regularly its own effectiveness and safety. 50 Increasing emphasis is now being placed on clinical audit in all aspects of medicine and especially in anaesthesia,s I and audit of pain control is part of the statement on acute pain made by the Faculty of Anaesthetists of the Royal Australasian College of Surgeons. The significance of PCA in postoperative pain management has been highlighted by a recent working party report from the Colleges of Anaesthetists and Surgeons of England. 18 This report, 'Pain after Surgery', emphasised the importance of this therapy as a 'major advance' in the field of pain relief, but stressed that potential problems such as respiratory depression and excessive sedation need consideration. Improvement in methods, clinical audit and constant critical appraisal also help in preventing accidents.
Initially, PCA was greeted with a degree of apprehension and scepticism reSUlting from concerns over the safety of the pumps themselves and possible consequences to patients should these malfunction. This was compounded by a reluctance of nurses and doctors to put patients in control of their own therapy, a unique scenario in hospital practice. However, since the benefits to the patient, doctor, nurse and hospital have been identified, this fear has been gradually eroded. Medical staff can prescribe an analgesic in such a way that allows patients to reach their own individual analgesic state, rather than fixed dose prescriptions which are known to be generally ineffective. 52 Patients can therefore titrate analgesia to their own end-point and undertake ward activities (e.g. physiotherapy) more effectively. Nurses are able to spend less time in the assessment, preparation and administration of analgesic agents, resulting in more time for direct patient care. Finally, total savings on nursing time 53 and reduction in hospital stay9 may prove to be cost-beneficial with PCA in comparison with the more traditional analgesic options although this has yet to be rigorously studied.
The inception of a PCA service is more than simply the purchase of a pump and attaching it to a patient: anaesthetic, surgical, nursing, pharmacy and biomedical engineering staff need to cooperate to provide a coherent structure in which to draw up guidelines for use and also with treatment regimens. 19 By careful planning and continuing assessments the safety of this therapeutic option can be maintained.
